GPR65 and neoplasm: That VEGFA and GPR65 DKO tumors show restoration of CAR T susceptibility and that this reduces the TME macrophage number and tumor burden implicate tumor-produced VEGFA as a key mediator of CAR T resistance in the B-ALL system.